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Abstract
Background: Constipation is a common symptom for patients receiving palliative care. Whilst international clinical
guidelines are available on the clinical management of constipation for people with advanced cancer receiving
specialist palliative care (SPC), the extent to which the guidelines are implemented in practice is unclear. This study
aimed to examine clinical practices for the assessment and management of constipation for patients with advanced
cancer within inpatient SPC settings.
Methods: A multi-site retrospective case-note review was conducted, consisting of 150 patient case-notes from
three inpatient SPC units across the United Kingdom between August 2016 and May 2017. The variables selected
for review were determined by the recommendations within the clinical guidelines. Descriptive statistics, cross
tabulation, chi square, and bivariate correlations were used to examine clinical practices compared to policy
guidelines for the assessment and management of constipation. Reporting was structured by the STROBE checklist
for observational research (Additional File 2).
Results: A comprehensive assessment, including a full history and performing a physical exam, was recorded for 109
patients (73%), however, no standardised documentation was utilised. Assessment was nurse led, with variable
involvement across sites of other members of the multidisciplinary team (MDT). Education on prevention was
documented in 30 (20%) case-notes, and 53% recorded evidence of non-pharmacological intervention. Age, gender,
and reason for admission did not impact on the likelihood of receiving a comprehensive assessment, education, or
non-pharmacological intervention, however, significant differences were evident between sites. Pharmacological
management was well developed and aligned to the guidelines however, 33% of patient case-notes recorded no
information on the titration of laxatives. Twelve percent of patients experienced partial or complete bowel obstruction,
and management strategies were variable.
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Conclusions: Constipation management is driven by a pharmacological approach, with little evidence of the
implementation of preventative and non-pharmacological strategies. The nurse plays a key coordinating role in
assessment; however, involvement and roles of the wider MDT varies. Accurate recording of care is essential when
examining clinical practice and identifying areas for improvement. Further education is needed to equip HCPs with the
knowledge and skills to ensure consistency in assessment and implementation of appropriate non-pharmacological/
preventative strategies.
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Background
Constipation is identified by unsatisfactory defecation due
to infrequent stools, difficulty passing stools, or the sensa-
tion of incomplete emptying [1]. This contributes to con-
siderable physical and psychological suffering for patients
and their families [2]. It is one of the most frequent
gastrointestinal complications encountered in clinical
practice in Western societies [3], with prevalence rates in-
creasing in older adults across community [4] nursing
homes [5], and specialist palliative care [6] settings. Whilst
constipation affects approximately 40% of patients receiv-
ing palliative care [7], this figure increases in specialist pal-
liative care (SPC) to greater than 66% [6]. Mercadante [6]
assessed the change in prevalence of constipation in pa-
tients with advanced cancer after one week of receiving
support from SPC. Patients with low bowel function
(bowel function index ≤28) experienced worsening of their
symptoms, and patients with normal bowel function at
initial assessment saw a worsening in their condition due
to lack of prevention or subsequent under-treatment. A
systematic review of constipation in SPC settings identi-
fied challenges for the assessment and management of this
symptom, including a lack of standardised assessment, an
overemphasis on pharmacological intervention, and lack
of preventative and non-pharmacological intervention [8].
Fragmented approaches to constipation management were
highlighted in a European Report on the burden of consti-
pation in an ageing population [9], and similar challenges
have been identified in previous hospice-based studies,
identifying a need to improve the overall clinical practices
of assessment and management of this symptom [10].
To guide clinical practice, a review of guidelines identified
twenty-two generic clinical guidelines for constipation
across North America, Europe, and Asia [11]. It was found,
however, there was only one guideline developed specific-
ally for palliative care, developed according to the principles
of the ADAPTE1 process [12] (Additional file 1). These
guidelines provide a useful starting point for evidence-
based practice as their recommendations are well sup-
ported by the research literature. Such recommendations
include: the need for a comprehensive assessment using the
Rome III criteria [13]; a complete documentation of med-
ical history; and the use of physical examination as part of
the comprehensive assessment process [14–17]. In order to
ensure effective management of constipation, it is recom-
mended that equal attention is paid to optimised toileting,
lifestyle modifications, and adjustment of activity levels,
alongside pharmacological management [18]. Very recent
clinical guidelines have been developed by the European
Society for Medical Oncology for the diagnosis, assess-
ment, and management of constipation [19], and similar
key recommendations are made compared to the previous
guidelines. This includes the need for a comprehensive as-
sessment, and a balance of strategies for prevention and
self-care and prescribed laxative therapy. It is noteworthy
that despite a systematic review of clinical trials highlight-
ing no evidence to support the use of one laxative over an-
other [20], previous research in both the UK and USA
identified preferences for specific laxatives, such as Senna
and Sodium Docusate [10, 21]. It is also noted that clinical
record keeping is an integral component in the delivery of
quality healthcare [22, 23], and essential to ensure high
quality care. Whilst key areas have been identified by the
guidelines and supported by the literature, questions exist
for these specific guidelines but also more generally across
oncology guideline implementation around the extent of
their implementation, HCP compliance to the guidelines
across patients, and impact in clinical practice [24]. There
is a dearth of real-world, patient-level, clinical evidence re-
garding the management of constipation for people with
advanced cancer in SPC settings.
Methods
Aim
To examine the clinical practice for the assessment and
management of constipation for patients with advanced
cancer within SPC settings.
Design
A descriptive, retrospective, observational study was con-
ducted. Multidisciplinary case-notes of patients (n = 150)
were reviewed in three SPC inpatient units. These notes
were reviewed using a process guided by Gilbert’s [25] eight
criteria, which includes abstractor training, explicit case se-
lection, clear definition of variables, standardised abstrac-
tion forms, meetings with abstractors to resolve disputes,
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monitoring performance of abstractors, blinding of abstrac-
tors, and testing for inter-rater agreement. These criteria
have been previously applied within palliative care research
focusing on end of life care provision, medication use, and
hospitalization [26] and were therefore deemed appropriate
for use in the current study. Reporting was structured by
the STROBE checklist for observational research to provide
a rigorous structure for reporting and to ensure sufficient
information is presented to allow for replication [27] (Add-
itional file 2).
Setting
In the United Kingdom (UK) in 2014/2015, at least 36,
000 people used SPC inpatient services; 80 % of these
patients had a diagnosis of cancer, and typically were ad-
mitted as part of a planned series of short stays between
one and four days [28]. Data were collected from a con-
venience sample of three SPC inpatient units associated
with one hospice organisation. The sites included repre-
sented three distinct regions of the UK, had previously
established collaborative links through involvement in
other research projects, and had expressed an interest in
this particular topic. The units comprised on average 22
beds, and admitted on average 329 patients each year.
Patients admitted from August 2016 to May 2017 were
included in the review.
Participants
On average, 987 patients are admitted to the three hos-
pices annually, of which approximately two thirds may
experience constipation. In conjunction with the re-
search leads at each clinical site, 150 patient case notes
were identified as an appropriate sample (50 per clinical
site) within a ten-month period to enable a suitable
comprehensive picture within the timeframe and avail-
able resources. Case-notes were reviewed chronologic-
ally from the beginning of the selected time-period until
150 had been identified which met the criteria:
 Adult patients with advanced cancer;
 Aged over 18 years;
 Admitted to the hospice in a specified period (if a
patient was readmitted, data were only extracted for
their first admission in this time period); and
 Constipation was noted as a problem in their
multidisciplinary records as per the Rome III
criteria.
Patient records were reviewed and data extracted
using a standardised data extraction form, adapted from
clinical guidelines for the management of constipation
[18], and in consultation with experts from the clinical
sites (See Additional file 1).
Data collection
Six health care professionals (HCPs) (five nurses and one
physiotherapist) with an interest in this clinical area and
working in the hospice volunteered as data abstractors. A
training session was held prior to data abstraction to clar-
ify inclusion criteria and practical considerations when
undertaking the review. Data abstractors accessed the pa-
tient’s clinical notes, either through an online system or
paper records, depending on accessibility at the site. After
data abstraction from five patient case-notes per site, a fol-
low up meeting was held to discuss any problems and en-
sure consistency in data recording.
Variables
Key variables for the review included assessment, preven-
tion, pharmacological and non-pharmacological manage-
ment strategies, opioid induced constipation (OIC), and
intestinal obstruction. Additional data included patient
demographics, medical history, and reason for referral.
The variables selected for review were determined by the
recommendations within the clinical guidelines [18]. The
use of a standardised form, multiple training sessions, and
ongoing discussions between the research team and data
abstractors increased confidence in the standardised com-
pletion of the forms.
Bias
To minimise the risk of selection bias, consecutive, chrono-
logical cases were selected to prevent data abstractors pick-
ing cases reflective of better practice. Measurement bias was
managed by selecting data abstractors who were separate to
the research team and had no prior investment in the pro-
ject. To prevent the risk of publication bias, all findings
from the review are presented, including ones which may
demonstrate poor documentation or poor clinical practice.
Data analysis
Data were entered into IBM SPSS Statistics v23 and de-
scriptive analysis undertaken. Variables were compared
across sites for similarities and differences. Cross tabula-
tion and chi squared tests were used to examine differ-
ences across variables. Bivariate correlation examined
relationships between continuous variables. If “not re-
corded” was noted for a question in more than 15% of
clinical case-notes, it has been discussed in the results as
this is a commonly cited maximum for acceptable miss-
ing data [29, 30].
Ethics
The study protocol, including case note review, was ap-
proved by the Office for Research Ethics Committees
Northern Ireland (ORECNI) (REC Reference 16/WM/
0352). To access case notes, each hospice site’s governance
committee granted approval. Patient data were anonymised
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before being transferred to the research team, ensuring no
patient could be identified within the data.
Results
Demographic profile
One hundred and fifty case-notes were reviewed (see
Table 1). The mean age of patients was 69 years (SD =
12.09). Over half of patients were female (n = 85; 56.7%),
and the main reason for admission was noted as symp-
tom control (n = 71; 47.3%). A third of patients were
recorded as living independently prior to admission (n =
50; 33.3%) with family support (n = 132; 88.0%). The
most frequent primary cancer sites were upper gastro-
intestinal (n = 35; 23.4%), lung (n = 29; 19.3%), and uro-
logical (n = 20; 13.3%). The mean length of stay in the
SPC inpatient unit was 18.83 days. Patients were pre-
scribed on average 1.25 laxatives (SD = 1.10) and 1.45
opioids (SD = 1.03). Medicines which acted on the
gastrointestinal system were prescribed most frequently
(mean = 2.31; SD = 1.40), followed by central nervous
system drugs (mean = 2.26; SD = 1.91) and drugs specif-
ically for pain (mean = 2.16; SD = 1.52).
Main findings
The results from the case note review are noted and sum-
marised against the key areas as outlined within the clin-
ical guideline recommendations (see Table 2). The results
from each of these respective areas are then outlined.
Constipation assessment
A comprehensive assessment, including taking a full his-
tory and performing a physical exam, was recorded for
109 patients (73%). On average 2.29 (SD = 2.00) physical
symptoms were recorded, the most frequent including in-
frequent bowel movements (n = 68; 45.3%), nausea (n =
57; 38.0%), abdominal pain (n = 50 33.3%), vomiting (n =
43; 28.7%), and poor appetite (n = 34; 22.7%). At one site
patients were statistically more likely to receive a compre-
hensive assessment than the other two sites (X2 (2, N =
145) = 6.048, p = .049). Age (p = .51), gender (p = .31), level
of independence (p = .53), and reason for admission (end
of life care compared to physical or psychological support)
(p = .18) did not significantly impact on the likelihood of
receiving a comprehensive assessment.
A lack of standardised documentation for assessment
was evident. Data abstractors noted the use of both online
and paper notes to document bowel assessment, making it
more challenging to access all the relevant information.
The Bristol Stool Chart (BSC) [31] was recorded for 144
(96%) patients within 24 h of admission, however, it was
unclear if the BSC was used to reassess constipation dur-
ing their time at the hospice. Two sites reported a “top to
toe” assessment for 20 patients (13.3%), suggesting a full
physical exam took place during the assessment.
The nurse was involved in 127 (84.7%) of initial assess-
ments across the three sites, however, variability was evi-
dent in the involvement of other members of the MDT.
At one site, assessments were conducted solely by the
nurse (n = 28; 56%), doctor (n = 7; 14%), or HCA (n = 2;
4%), and 10% (n = 5) were conducted by both a doctor
and nurse. The second site had 100% (n = 50) patients
assessed by the doctor, nurse, and HCA. The third site
had 39 patients (78%) assessed by both the doctor and
nurse, eight patients (16%) assessed solely by the nurse,
and two patients (4%) assessed solely by the doctor.
A quarter of case-notes had no recorded information on
the relevance or use of digital rectal examination (DRE).
Twenty-five case-notes (17%) recorded that a DRE had
been performed after three or more days without a bowel
movement. Only two case notes (1%) reported completion
of a DRE when the patient complained of incomplete
evacuation. The use of a DRE was not applicable to 50%
of case-notes reviewed (n = 75).
Constipation management
These findings will be focused on the key areas of pre-
vention, non-pharmacological management, and
pharmacological management.
Prevention
Education on preventative and non-drug measures was
documented in 30 (20%) reviewed case-notes, with the
majority provided at one site. Participants at one site
were significantly more likely to receive education com-
pared to the other two sites (X2 (2, N = 145) = 69.076,
p < .001). One site did not provide any documentation in
relation to the provision of education on preventative
measures. Age (p = .70), gender (p = .19), and reason for
admission (end of life care compared to physical or psy-
chological support) (p = .36) did not significantly impact
on the likelihood of receiving education. However, pa-
tients who did not require assistance with mobility were
more likely to receive education on preventative and
non-drug measures [X2 (3, N = 142) = 12.56, p = .006]
than those requiring assistance or who were bed-bound.
Non-Pharmacological management
Non-pharmacological strategies were recorded in 79 pa-
tient case-notes (53%). Such strategies included consider-
ations of diet and fluids (n = 55; 37%), ensuring privacy
(n = 52; 35%), mobility (n = 46; 31%), and optimised toilet-
ing (n = 28; 19%). Evidence of non-pharmacological strat-
egies were not explicitly recorded on 41 case-notes (27%),
and the remaining 20% of case-notes identified non-
pharmacological strategies as not discussed or not applic-
able. Age (p = .55), gender (p = .86), level of independence
(p = .43), and reason for admission (end of life care com-
pared to physical or psychological support) (p = .46) did
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not significantly impact on the likelihood of receiving
non-pharmacological intervention. However, there were
statistically significant differences between sites (X2 (2,
N = 142) = 11.962, p = .003).
Pharmacological management
Laxatives were recorded for 144 (96%) patients. The most
frequently administered laxative was Sodium Docusate, a
softening laxative, with approximately a quarter of patients
26% (n = 39) patients receiving this as their primary laxative
and 19% (n = 28) receiving it as a secondary laxative. This
was followed by Senna, a stimulant, with 18% of patients
(n = 27) receiving it as a primary laxative and a further 11%
(n = 17) receiving it as a secondary laxative. Of the patients
who required multiple laxatives (n = 115), a combination of
a softener and a stimulant were used in 59% of cases (n =
68). As would be expected, suppositories were more com-
monly used as a third line of pharmacological management,
Table 1 Demographic profile of patients
Characteristics N (%)
Location Northern Ireland (Belfast) 50 (33.3)
Scotland (Edinburgh) 50 (33.3)
England (West Midlands) 50 (33.3)
Gender Male 65 (43.3)
Female 85 (56.7)
Reason Admitted Symptom Control (Physical
or Psychological)
82 (54.7)
End of Life Care 65 (43.3)
Other 1 (.7)
Missing 2 (1.3)
Referral Source Specialist Palliative Care Team 65 (43.3)
Hospital (including outpatients) 50 (33.3)
Community Referral (including General
Practitioner and Nursing home)
29 (19.3)
Not Recorded 2(1.3)
Missing 4 (2.7)
Primary Cancer Site Upper GI 35 (23.4)
Lung 29 (19.3)
Urological 20 (13.3)
Breast 11 (7.3)
Colorectal 11 (7.3)
Gynaecological 11 (7.3)
Haematological 9 (6.0)
CNS 8 (5.3)
Head and Neck 7 (4.7)
Skin 3 (2.0)
Bone 2 (1.4)
Other 4 (2.7)
Mobility Independent 50 (33.3)
Assistance of One 34 (22.7)
Assistance of Two 31 (20.7)
Bed Bound 32 (21.3)
Missing 3 (2.0)
Family Support Yes 132 (88.0)
No 11 (7.3)
Missing 7 (4.7)
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Table 2 Case note comparison to guidelines
Case-note review question All sites n(%) yes
Clinical Guideline: Assessment
1.1 A thorough history and physical examination are
recommended as essential components of the assessment process.
Was a comprehensive assessment carried out? 109 (73)
Constipation assessment scales are not recommended for routine
use.
Was an assessment tool used? 144 (96)
1.3 A digital rectal examination (DRE) is required to exclude faecal
impaction if it has been more than 3 days since the last bowel
movement or if the patient complains of incomplete evacuation
aDRE performed when it’s been
3 or more days since last evacuation
25 (17)
aDRE performed when the patient
complains of incomplete evacuation
2 (1)
1.5 A plain film of the abdomen (PFA) is not recommended for
routine evaluation but may be useful in combination with history
and examination in certain patients
Was a PFA performed? 5 (3)
Clinical Guideline: Education
2.1 Education on the importance of non-drug measures is essential
to enable patients and caregivers to take an active role in constipa-
tion prevention.
aWas education on non-drug measures recorded? 30 (20)
Clinical guidelines: Management
3.1 Attention should be paid to the provision of optimised
toileting while ensuring adequate privacy and dignity.
aWas there evidence of consideration of optimised toileting? 28 (19)
aWas there evidence of consideration of privacy? 52 (35)
3.2 Consideration should be given to lifestyle modification
(adjustment of diet and activity levels within a patient’s limitations).
aWas there evidence of consideration of diet and fluids? 55 (37)
aWas there evidence of consideration of mobility? 46 (31)
Where there is no evidence to differentiate between medications
in terms of efficacy, tolerability and side effect profile, and where
clinical expertise allows, the medication with lowest cost base
should be used.
Primary Laxative (PL): Bisacodyl 5 (3)
PL: Senna 27 (18)
PL: Lactulose 3 (2)
PL: Glycerol 3 (2)
PL: Docusate 39 (26)
PL: Sodium Picosulphate 14 (9)
PL: Macrogols 33 (22.0)
PL: Other 8 (5.3)
PL: None administered 14 (9.3)
4.3 The combination of a softening & stimulating laxative is often
required. Optimisation of a single laxative is recommended prior to
the addition of a second agent.
Was a combination of a softening and a
stimulating laxative used?
68 (45)
aWas optimisation of a single laxative
achieved prior to the addition of a second agent?
48 (32)
4.4 The laxative dose should be titrated daily or alternate days
according to response.
aWas the laxative dose titrated: Daily 20 (13)
aWas the laxative dose titrated: On alternate days 11 (7)
Clinical guidelines: Opioid induced constipation
5.1 The development of OIC should be anticipated. A bowel
regimen should be initiated at the commencement of opioid
therapy
Was a bowel regimen initiated at the
commencement of opioid therapy?
79 (53)
5.2 In the management of OIC optimised monotherapy with a
stimulant laxative is essential followed by the addition of a
softener if required.
Was optimisation of a stimulant laxative
achieved prior to the addition
of a softening laxative?
17 (14.2)
Clinical guidelines: Intestinal Obstruction
6.1 A stool softener should be considered in partial intestinal
obstruction (IO).
Stimulant laxatives should be avoided.
In patients with partial IO: was the use of a
stool softener considered?
8 (50)
In patients with partial IO: were stimulant laxatives avoided? 1 (8)
6.2 In complete IO, the use of all laxatives should be avoided as
even softening laxatives have some peristaltic action.
In patients with complete IO: were all laxatives avoided? 1 (14)
a Not recorded in 15% or more of case-notes
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with Bisacodyl suppositories (n = 17; 11%) and Glycerin
suppositories (n = 13; 9%) ranking as the top two third level
treatments. In a third of patient case-notes (n = 49; 33%),
no information was recorded regarding the titration of laxa-
tives. Titration of laxatives daily or on alternate days were
recorded for 13% (n = 20) and 7% (n = 11) of patients re-
spectively. Daily titration varied from 0 to 30% across sites.
Opioid induced constipation (OIC)
Eighty percent (n = 120) of patient notes evidenced re-
ceipt of opioids; 17 of whom were on more than three
opioids. Patients who were prescribed a higher number
of opioids were also prescribed a higher number of laxa-
tives (p = .036). Out of the 120 patients receiving opioids,
17 (14.2%) achieved optimisation of a stimulant prior to
the addition of a softening laxative. Details on optimisa-
tion of a stimulant prior to the addition of a softening
laxative was not recorded for 18.3% of patients (n = 22).
Intestinal obstruction
Partial or complete bowel obstruction was not applicable
to the majority of patients (n = 132). In the 16 patients
who had data recorded regarding the use of a stool soft-
ener for partial intestinal obstruction, 50% had received a
softener (n = 8) and 50% had not (n = 8). Stimulants were
only avoided in one patient with partial obstruction. Seven
case-notes recorded complete intestinal obstruction, only
one of which showed the avoidance of all laxatives.
Discussion
This study examined the recorded clinical practices of
the assessment and management of constipation for pa-
tients with advanced cancer in three SPC inpatient units,
and identified variations within and across sites in one
organisation in both assessment and management prac-
tices from clinical guidelines recommendations.
Approximately three quarters of patients in this study
received a comprehensive assessment, and other related
symptoms such as nausea and vomiting were also re-
corded, demonstrating good clinical practice and a holistic
approach to assessment. Globally it is advocated in both
clinical guidelines and research that the assessment of
constipation should combine the following elements: use
of the Rome III criteria [13]; a medical history; and a phys-
ical exam [14–18]. In the hospice population, great diver-
sity in the physical capacity of individuals (33.3%
independent and 21.3% bedbound), calls for assessment to
consider not just the patient’s bowel movements, but also
a full history of their general health, needs, and circum-
stances as part of person-centred, holistic palliative care
[32]. However, the findings showed no evidence of the use
of standardised documentation for assessment or any fur-
ther follow up, therefore, this may contribute to subjectiv-
ity in the assessment process and potentially overlooking
patients who are constipated but their symptoms not ap-
propriately documented to help reach a diagnosis.
The guidelines identify best practice as both constipa-
tion assessment and management delivered within a
MDT with a clearly identified clinical lead and active
communication between all team members [18]. Fur-
thermore, a recent meta-synthesis of qualitative evidence
identified the key coordinating role of the nurse in pal-
liative care between the patient, family, and other HCPs
as a fundamental aspect of their overall role [33]. In line
with the guidelines and this meta-synthesis, the nurse
had a leading role in the assessment and management of
constipation, with variable involvement from other
members of the MDT as appropriate and when required.
Possible reasons for variability may be attributable to
limits in guideline diffusion within the SPC unit, or to
perceived role in constipation assessment and manage-
ment, or due to staffing availability, therefore, additional
signposting may support other roles within the SPC set-
ting to identify when their expertise is required across
the assessment and management process.
Despite the clinical guideline’s recommendation of the
use of DRE, only 25% of patients received a DRE after
three days without a bowel evacuation, however, clinical
judgment is key to consider when interpreting this find-
ing. Given the clinical pathology of many patients within
SPC such as reduced mobility, reduced oral intake, and
pharmacology, the cause of constipation can often be
identified without an invasive procedure such as a DRE.
In addition, almost half (n = 65; 43.3%) of the patients
included in the chart review were admitted for end of
life care. The guidelines state that when caring for a pa-
tient who is at the end of life, rectal intervention is rarely
necessary [18], therefore, it was appropriate to see lim-
ited use of this intervention.
A palliative care approach calls for symptom management
to be addressed as a multidimensional experience, consider-
ing the non-physical aspects of pain within assessment and
management [34]. Pharmacological management was well
developed and aligned to the guidelines, which state that
the medication with lowest cost base should be used where
there is no evidence to differentiate between medications in
terms of efficacy, tolerability and side effect profile [18]. A
Cochrane review of clinical trials highlighted no evidence to
support the efficacy of one laxative over another [20], there-
fore, laxatives with a lower cost base should be selected. In
the UK, Senna, lactulose, and docusate are the three oral
laxatives with the lowest cost base (£0.80, £1.30, and £1.95
per 14 day treatment respectively [35]), and these options
were used as primary laxatives for approximately half of pa-
tients (46.0%), mirroring findings from previous hospice-
based research in the UK and USA [10, 21]. However, find-
ings highlighted that pharmacological strategies were more
likely to be documented, resulting in a lack of evidence that
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non-pharmacological interventions were utilised and ques-
tioning the use of a holistic approach to care [36]. Best prac-
tice is based on a balance between strategies for prevention
and self-care and prescribed oral and rectal laxative therapy
[19], however, this is not reflected in the current study. Con-
versations around the prevention of constipation, which
were a key element within the guidelines, were only re-
corded on 20% of patient charts. Whilst equal attention
should be paid to optimised toileting, lifestyle modifications,
and adjustment of activity levels [18] as well as pharmaco-
logical management, non-pharmacological interventions
were only documented in 53% of case-notes, compared to
96% documenting pharmacological intervention. These
findings call for a greater awareness of the holistic ap-
proach necessary in the prevention and management of
constipation in palliative care. Whilst patients may be
implementing these independently of their hospice plan of
care, preventative and non-pharmacological strategies are
of equal relevance to pharmacological care and therefore
should also be discussed by HCPs and recorded alongside
pharmacological intervention.
Previous studies have shown that only a small propor-
tion of the cost of managing constipation in a SPC in-
patient unit was related to drug expenditure (13%),
compared to 85% of cost for staff time [37]. The cost to
older adults can be seen in terms of the reported nega-
tive impact on physical, psychological, and social well-
being in everyday life [38]. This cost to older adults was
also found in a recent systematic review within SPC set-
tings, therefore, it is essential that this symptom is well
managed [8]. Good clinical record keeping is an integral
component in good professional practice and the deliv-
ery of quality healthcare, and would enable enhanced
communication within the MDT, reducing the staff time
required to manage constipation [22, 23, 39]. Effective
assessment and management of constipation through
adherence to clinical guidelines along with good docu-
mentation of all aspects of assessment and management
may assist in minimising the burden to both staff and
patients.
Interpretation of the findings must be undertaken cau-
tiously, due to the inability to differentiate between data
that were not recorded, and clinical activities that were
not undertaken. Non-recorded data limits the ability to
provide a full picture of what happens in this setting re-
garding the assessment and management of constipation.
However, this study is able to provide useful insights into
data recording and some ways in which the problem of
constipation is it being managed within this practice set-
ting. Strengths of this research are also acknowledged.
Through the use of Gilbert’s [25] evaluative criteria, the
methodological approach has been conducted in a rigor-
ous manner, in particular the training and follow up verifi-
cation with data abstractors after collecting five case-
notes. This rigorous approach has increased the replicabil-
ity of the study and reliability of the findings.
Conclusions
This study provides an insight into the recorded clinical
practices of constipation assessment and management
in inpatient SPC settings. Despite existing clinical
guidelines, clinical records show great variability within
and between sites. Whilst comprehensive, holistic as-
sessments were evident for 73% of patients, a lack of
standardised documentation or evidence of follow up
may result in the identification, diagnosis, and subse-
quent treatment of constipation being missed for some
patients within this setting. The nurse, supported by
standardised documentation procedures, plays a key co-
ordinating role in identifying and assessing constipa-
tion. Application of pharmacological interventions
appeared to adhere to clinical guidelines, but preven-
tion and non-pharmacological interventions requires
further attention. Accurate documentation is essential
for not only identifying areas of practice that require
improvement, but areas of good practice. Further edu-
cation is needed to equip HCPs with the knowledge
and skills to perform not only a full assessment, but
also to use appropriate non-pharmacological and pre-
ventative strategies. Owing to gaps in recording, it is
vital that SPC settings consider ways to support the im-
plementation of new documenting and recording strat-
egies which are readily available to the MDT to enable
transparency of care and maintain good clinical stan-
dards. Future research should consider identifying staff
knowledge of constipation, and the use and effective-
ness of non-pharmacological interventions across clin-
ical settings for this group of patients.
Endnotes
1The ADAPTE process provides a systematic approach
to adapting guidelines produced in one setting for use in
a different cultural and organizational context. The
adaptation consists of three main phases; set-up phase,
adaptation phase, and finalization phase.
Additional files
Additional file 1: Management of Constipation in Adult Patients
Receiving Palliative Care Guidelines Summary. (DOCX 326 kb)
Additional file 2: STROBE Statement—checklist of items that should be
included in reports of observational studies. (DOCX 40 kb)
Abbreviations
BSC: Bristol Stool Chart; DRE: Digital rectal examination; HCPs: Healthcare
Professionals; MDT: Multi-disciplinary team; OIC: Opioid induced constipation;
ORECNI: Office for Research Ethics Committees Northern Ireland;
SPC: Specialist palliative care; UK: United Kingdom
McIlfatrick et al. BMC Palliative Care           (2019) 18:57 Page 8 of 10
Acknowledgements
The authors would like to acknowledge members of the research steering
group for their contribution to the design of the larger research project: Dr.
John MacArtney, Professor Max Watson, and Mrs. Eileen Wright. We would
also like to acknowledge Angela McAleer for clinical guidance, Rachel Perry
for site coordination, and Mary Armstrong, Gail Watson, Rachel Grubb,
Gemma Glover, Pippa Grundy and Robert Przekwas for undertaking the case-
note reviews.
Authors’ contributions
All authors made substantial contributions to the conception and design of
the work. AF and LGW facilitated the acquisition of data, SM, DM, EB, PS, and
FH led on interpreting and drafting the work, all authors revised it critically,
and all authors read and approved the final version of the manuscript.
Funding
This work was supported by a research grant awarded to Professor Sonja
McIlfatrick by Marie Curie UK (REF MCCC-RP-16-A20993). The funding body
had no role in the design of the study and collection, analysis, and interpret-
ation of data and in writing the manuscript.
Availability of data and materials
The datasets used and/or analysed during the current study are available
from the corresponding author on reasonable request.
Ethics approval and consent to participate
The study was approved by the Office for Research Ethics Committees
Northern Ireland (ORECNI) (RECA Reference 16/WM/0352). Permission to
access patient notes for the purpose of this study was obtained from each
hospice. Approval was also obtained from the Hospice Research Governance
Committees in each location. Data collection was conducted by hospice staff
who routinely access patient notes, and all data was anonymised prior to
sharing with the research team.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1Institute of Nursing and Health Research, Ulster University, Shore Road,
Newtownabbey, Co Antrim BT37 0QB, UK. 2Marie Curie Hospice, Balornock
Rd, Glasgow G21 3US, UK. 3Queen’s University Belfast, University Rd, Belfast
BT7 1NN, UK. 4Marie Curie Hospice, Frogston Road West, Edinburgh EH10
7DR, UK. 5Université de Lausanne, Lausanne, Switzerland.
Received: 18 April 2019 Accepted: 19 June 2019
References
1. NICE. Constipation [Internet]. Clinical knowledge summaries. 2017 Jun [cited
2018 Dec 13]. Available from: https://cks.nice.org.uk/
constipation#!topicsummary
2. Andrews A, Morgan G. Constipation management in palliative care:
treatments and the potential of independent nurse prescribing. Int J Palliat
Nurs. 2012;18(1):17–22 [cited 2016 Oct 7]. Available from: http://www.
magonlinelibrary.com/doi/abs/10.12968/ijpn.2012.18.1.17.
3. Gallegos-Orozco JF, Foxx-Orenstein AE, Sterler SM, Stoa JM. Chronic
constipation in the elderly. Am J Gastroenterol. 2012;107(1):18–25 [cited 2018
Dec 13]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21989145.
4. Rao SSC, Go JT. Update on the management of constipation in the elderly:
new treatment options. Clin Interv Aging. 2010;5:163–71 [cited 2018 Dec
13]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20711435.
5. Fosnes GS, Lydersen S, Farup PG. Drugs and constipation in elderly in
nursing homes: what is the relation? Gastroenterol Res Pract. 2012;2012:
290231 [cited 2018 Dec 13]. Available from: http://www.ncbi.nlm.nih.gov/
pubmed/22505881.
6. Mercadante S, Masedu F, Maltoni M, De Giovanni D, Montanari L,
Pittureri C, et al. The prevalence of constipation at admission and after
1 week of palliative care: a multi-center study. Curr Med Res Opin.
2018;34(7):1187–92 [cited 2018 Aug 24]. Available from: http://www.
ncbi.nlm.nih.gov/pubmed/28728515.
7. Clark K, Smith JM, Currow DC. The prevalence of bowel problems reported in a
palliative care population. J Pain Symptom Manag. 2012;43(6):993–1000 [cited
2018 Jan 9]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22651945.
8. Muldrew DH, Hasson F, Carduff E, Clarke M, Coast J, Finucane A, et al.
Assessment and management of constipation for patients receiving
palliative care in specialist palliative care settings: a systematic review of the
literature. Palliat Med 2018;026921631775251 [cited 2018 Feb 19]. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/29431016.
9. International Longevity Centre UK. The burden of constipation in our
ageing population: working towards better solutions. Brussels; 2013.
10. Goodman M, Low J, Wilkinson S. Constipation management in palliative
care: a survey of practices in the United Kingdom. J Pain Symptom Manag.
2005;29(3):238–44.
11. Tian H, Ding C, Gong J, Ge X, McFarland LV, Gu L, et al. An appraisal of clinical
practice guidelines for constipation: a right attitude towards to guidelines.
BMC Gastroenterol. 2016;16(1):52 [cited 2017 Aug 16]. Available from: http://
bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-016-0466-8.
12. The ADAPT Collection. The ADAPTE process: resource toolkit for guideline
adaptation. Version 2.0 [internet]. 2009 [cited 2012 Jun 2]. Available from:
https://www.g-i-n.net/document-store/working-groups-documents/
adaptation/adapte-resource-toolkit-guideline-adaptation-2-0.pdf.
13. Rome Foundation. Rome III diagnostic criteria [internet]. Rome III disorders
criteria appendix. 2006. Available from: https://www.theromefoundation.org/
assets/pdf/19_RomeIII_apA_885-898.pdf.
14. Bharucha AE, Dorn SD, Lembo A, Pressman A. American gastroenterological
association medical position statement on constipation. Gastroenterology.
2013;144(1):211–7 [cited 2017 Aug 17]. Available from: http://www.ncbi.nlm.
nih.gov/pubmed/23261064.
15. Larkin PJ, Sykes NP, Centeno C, Ellershaw JE, Elsner F, Eugene B, et al. The
management of constipation in palliative care: clinical practice
recommendations. Palliat Med. 2008;22(7):796–807.
16. Librach SL, Bouvette M, De Angelis C, Farley J, Oneschuk D, Pereira JL, et al.
Consensus recommendations for the Management of Constipation in patients
with advanced, progressive illness. J Pain Symptom Manag. 2010;40(5):761–73.
17. Lindberg G, Hamid SS, Malfertheiner P, Thomsen OO, Fernandez B, Garisch
JJ, et al. World Gastroenterology Organisation global guideline:
Constipation--a global perspective. J Clin Gastroenterol. 2011;45(6):483–7
[cited 2017 Aug 17]. Available from: https://umexpert.um.edu.my/file/
publication/00000557_79604.pdf.
18. National Clinical Effectiveness Committee. Management of Constipation in
Adult Patients Receiving Palliative Care National Clinical Guideline No. 10
November 2015. 2015.
19. Larkin PJ, Cherny NI, La C, Guglielmo M, Ostgathe C, Scotte F, et al.
Diagnosis, assessment and Management of Constipation in advanced
Cancer: ESMO clinical practice guidelines. Ann Oncol. 2018;29(supplement
4):iv111–25 [cited 2019 Jan 30]. Available from: https://www.esmo.org/
Guidelines/Supportive-and-Palliative-Care/Diagnosis-Assessment-and-
Management-of-Constipation-in-Advanced-Cancer.
20. Candy B, Jones L, Larkin PJ, Vickerstaff V, Tookman A, Stone P. Laxatives for
the management of constipation in people receiving palliative care.
Cochrane Database Syst Rev. 2015;(5) [cited 2016 Nov 4]. Available from:
http://doi.wiley.com/10.1002/14651858.CD003448.pub4.
21. Sera L, McPherson ML, Holmes HM. Commonly prescribed medications in a
population of hospice patients. Am J Hosp Palliat Med. 2014;31(2):126–31
[cited 2017 Aug 15]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/
23408370.
22. General Medical Council. Code of Conduct [Internet]. 2015 [cited 2019 Apr
11]. Available from: https://www.gmc-uk.org/about/how-we-work/
governance/council/code-of-conduct
23. Nursing and Midwifery Council. The Code. Professional standards of practice
for nurses, midwifes and nursing associates [internet]. Nursing and
midwifery council. 2018 [cited 2019 Apr 11]. Available from: https://www.
nmc.org.uk/globalassets/sitedocuments/nmc-publications/nmc-code.pdf
24. Peterson DE, Bensadoun RJ, Lalla R V., McGuire DB. Supportive care
treatment guidelines: value, limitations, and opportunities. In: Seminars in
oncology [internet]. 2011 [cited 2019 Jun 6]. p. 367–373. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/21600365.
25. Gilbert EH, Lowenstein SR, Koziol-McLain J, Barta DC, Steiner J. Chart reviews
in emergency medicine research: where are the methods? Ann Emerg Med.
McIlfatrick et al. BMC Palliative Care           (2019) 18:57 Page 9 of 10
1996;27(3):305–8 [cited 2018 May 17]. Available from: http://www.ncbi.nlm.
nih.gov/pubmed/8599488.
26. Wickson-griffiths A, Kaasalainen S, Ploeg J, Mcainey C. Revisiting
retrospective chart review: An evaluation of nursing home palliative and
end-of-life care research. Palliat Med Care. 2014;1(2):8 [cited 2017 Nov 23].
Available from: https://symbiosisonlinepublishing.com/palliative-medicine-
care/palliative-medicine-care10.php.
27. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke
JP, et al. The strengthening the reporting of observational studies in
epidemiology (STROBE) statement: guidelines for reporting observational
studies. Ann Intern Med. 2007;147(8):573–7 [cited 2018 Nov 2]. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/17938396.
28. National Council for Palliative Care. National Survey of Patient Activity Data
for Specialist Palliative Care Services [Internet]. London; 2016 [cited 2018
Feb 16]. Available from: http://www.endoflifecare-intelligence.org.uk/
resources/publications/mdsreport2014.
29. Fox-Wasylyshyn SM, El-Masri MM. Handling missing data in self-report
measures [internet]. Vol. 28, research in nursing and health. Wiley-Blackwell;
2005 [cited 2018 Jun 29]. p. 488–495. Available from: http://doi.wiley.com/
10.1002/nur.20100.
30. Dong Y, Peng C-YJ. Principled missing data methods for researchers.
Springerplus. 2013;2(1):222 [cited 2018 Jun 29]. Available from: http://www.
ncbi.nlm.nih.gov/pubmed/23853744.
31. National Institute for Clinical Excellence. Bristol Stool Chart. Guid Resour. 2013;
32. McIlfatrick S, Hasson F. Evaluating an holistic assessment tool for palliative
care practice. J Clin Nurs. 2014;23(7–8):1064–75 [cited 2017 Apr 11].
Available from: http://doi.wiley.com/10.1111/jocn.12320.
33. Sekse RJT, Hunskår I, Ellingsen S. The nurse’s role in palliative care: a
qualitative meta-synthesis. J Clin Nurs. 2018;27:e21–38 [cited 2019 Apr 17].
Available from: http://doi.wiley.com/10.1111/jocn.13912.
34. Wilkie DJ, Ezenwa MO. Pain and symptom management in palliative care
and at end of life. Nurs Outlook. 2012;60(6):357–64 [cited 2018 Dec 17].
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22985972.
35. Regional drugs and therapeutics Centre. Cost comparison charts [internet].
2018 [cited 2019 Apr 12]. Available from: http://gmmmg.nhs.uk/docs/cost_
comparison_charts.pdf.
36. Payne S, Seymour J, Ingleton C. Palliative care nursing : principles and
evidence for practice [internet]. Open University Press; 2008 [cited 2018 Nov
2]. 717 p. Available from: https://catalogue.library.ulster.ac.uk/items/
1217117?query=palliative+care+nursing&resultsUri=
items%3Fquery%3Dpalliative%2Bcare%2Bnursing%26offset%3D0.
37. Wee B, Adams A, Thompson K, Percival F, Burslem K, Jobanputra M. How
much does it cost a specialist palliative care unit to manage constipation in
patients receiving opioid therapy? J Pain Symptom Manag. 2010;39(4):644–
54 [cited 2017 Mar 23]. Available from: http://linkinghub.elsevier.com/
retrieve/pii/S0885392410000801.
38. Munch L, Tvistholm N, Trosborg I, Konradsen H. Living with
constipation—older people’s experiences and strategies with constipation
before and during hospitalization. Int J Qual Stud Health Well-being. 2016;
11:30732 [cited 2019 Apr 12]. Available from: http://www.ncbi.nlm.nih.gov/
pubmed/27121271.
39. Mathioudakis A, Rousalova I, Gagnat AA, Saad N, Hardavella G. How to keep
good clinical records. Breathe (Sheffield, England). 2016;12(4):369–73 [cited
2018 Dec 17]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28210323.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
McIlfatrick et al. BMC Palliative Care           (2019) 18:57 Page 10 of 10
